President Joe Biden is directing HHS, through an executive order, to use the Innovation Center to lower drug prices; the US extended the COVID-19 public health emergency for another 90 days; the CDC reported that 75% of teenagers experienced adverse childhood experiences in 2021, which worsened their mental health.
The White House announced that President Joe Biden will sign an executive order directing HHS to explore new ways to lower prescription drug costs. Specifically, the order directs HHS to use the Innovation Center, which focuses on alternative payment models, to expand into drug pricing affordability. HHS will have 90 days to report its plans to lower drug prices. The president will sign the order during a trip to the West Coast Friday and Saturday as Medicare open enrollment season begins.
HHS Thursday extended the COVID-19 public health emergency for another 90 days. The declaration has been renewed every 90 days since it was first put into place in January 2020. White House officials are concerned about upcoming colder weather and fall and winter holidays, The Hill reported.
The CDC reported Thursday that most US adolescents had adverse childhood experiences (ACEs) during the pandemic, worsening their mental health. Physical abuse, emotional abuse, food insecurity, or loss of a parent’s job were exerienced by nearly 75% of teenagers last year, as well as electronic bullying, dating violence, and sexual violence. Data from the 2021 Adolescent Behaviors and Experiences Survey indicate that rates of poor current mental health and reporting a past-year suicide attempt among teens with 4 or more ACEs were 4 and 25 times as high as in those without ACEs, respectively.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More